Mednet Logo

For patients on ado-trastuzumab emtansine (T-DM1) for metastatic HR+HER2+ breast cancer, do you prescribe concurrent hormone blockade?

Community PollStarted

Do you give concurrent endocrine therapy when giving T-DM1 for triple positive metastatic disease?

74 physicians have voted

Join Mednetto vote and see how they answered.